HIGH GRADE NEUROENDOCRINE CANCER

Clinical trials for HIGH GRADE NEUROENDOCRINE CANCER explained in plain language.

Never miss a new study

Get alerted when new HIGH GRADE NEUROENDOCRINE CANCER trials appear

Sign up with your email to follow new studies for HIGH GRADE NEUROENDOCRINE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill targets 'MYC' cancer genes in advanced tumors

Disease control Ongoing

This early-phase study is testing an experimental oral medication called MRT-2359 in people with advanced cancers that have run out of standard treatment options. The trial focuses on several types of solid tumors and lymphoma, particularly those driven by specific genes called L…

Matched conditions: HIGH GRADE NEUROENDOCRINE CANCER

Phase: PHASE1, PHASE2 • Sponsor: Monte Rosa Therapeutics, Inc • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

HIGH GRADE NEUROENDOCRINE CANCER

Get alerted when new HIGH GRADE NEUROENDOCRINE CANCER trials appear

New pill targets 'MYC' cancer genes in advanced tumors